Product Information

ERYTHROMYCIN DR 250 MG CAP is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $5.9600 per EA under NDC 75907007601. Its NADAC has been published 96 times since Oct 23, 2024.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERYTHROMYCIN DR 250 MG CAP

erythromycin
$5.9600per EA

Strength

250 mg/1

NDC

75907007601

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE PELLETS

Route

ORAL

Effective Date

4/22/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Authorized Generic (NDA)

FDA Application

NDA050536

FDA Approved

Before 1982

TE Code

AB

On Market Since

9/1/2024

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERYTHROMYCIN DR 250 MG CAP has been published 96 times since Oct 23, 2024, and over the history we have for it it has declined 10.7%. The table below summarizes its recorded NADAC range and movement.

Current price$5.9600 per EA
All-time high$6.6741 (May 14, 2025)
All-time low$5.9600 (Apr 22, 2026)
52-week high$6.6472
52-week low$5.9600
Median price$6.3913
Average price$6.3864
Largest weekly change-5.4% (Apr 22, 2026)
Weeks tracked96
Tracking sinceOct 23, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-7.1%

1Y

-3.2%

3Y

N/A

5Y

N/A

All

-10.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the erythromycin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ERYTHROMYCIN DR 250 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 250 MG CAP, manufactured by Dr. Reddy's Laboratories Inc., is $5.9600 per EA (NDC 75907007601), effective Aug 19, 2026.

How has the price of ERYTHROMYCIN DR 250 MG CAP changed over time?

Over the history we have for it, the NADAC for ERYTHROMYCIN DR 250 MG CAP has declined 10.7%. It has been tracked across 96 weekly CMS publications since Oct 23, 2024.

What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 250 MG CAP?

Since Oct 23, 2024, the NADAC for ERYTHROMYCIN DR 250 MG CAP has ranged from a low of $5.9600 (Apr 22, 2026) to a high of $6.6741 (May 14, 2025), with a median of $6.3913 per EA.

Are there cheaper alternatives to ERYTHROMYCIN DR 250 MG CAP?

No other NADAC-published product currently shares the active ingredient and strength of ERYTHROMYCIN DR 250 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ERYTHROMYCIN DR 250 MG CAP?

ERYTHROMYCIN DR 250 MG CAP (NDC 75907007601) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.